1 |
Sabichi AL, Lee JJ, Taylor RJ, et al (2006). Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group study. Clin Cancer Res, 12, 2178-84.
DOI
ScienceOn
|
2 |
Sanda MG, Dunn RL, Michalski J, et al (2008). Quality of life and satisfaction with outcome among prostate cancer survivors. N Engl J Med, 358, 1250-61.
DOI
ScienceOn
|
3 |
Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29.
DOI
ScienceOn
|
4 |
Silberstein JL, Parsons JK (2010). Prostate cancer prevention: concepts and clinical recommendations. Prostate Cancer Prostatic Dis, 13, 300-6.
DOI
ScienceOn
|
5 |
Ware JH, Zhou Z, Kopelovich L, et al (2006). Evaluation of cancer chemopreventive agents using clones derived from a human prostate cancer cell line. Anticancer Res, 26, 4177-83.
|
6 |
Zhang J, Wang L, Li G, et al (2011). Mouse prostate proteomes are differentially altered by supranutritional intake of four selenium compounds. Nutr Cancer, 63, 778-89.
DOI
ScienceOn
|
7 |
Zhang Y, Skolarus TA, Miller DC, et al (2011). Understanding prostate cancer spending growth among medicare beneficiaries. Urology, 77, 326-31.
DOI
ScienceOn
|
8 |
Clark LC, Combs GF, Turnbull BW, et al (1996). Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA, 276, 1957-63
DOI
ScienceOn
|
9 |
Clark LC, Dalkin B, Krongrad A, et al (1998). Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol, 81, 730-4.
DOI
ScienceOn
|
10 |
Diwadkar-Navsariwala V, Prins GS, Swanson SM, et al (2006). Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model. Proc Natl Acad Sci U S A, 103, 8179-84.
DOI
ScienceOn
|
11 |
Hu JC, Gu X, Lipsitz SR, et al (2009). Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA, 302, 1557-64.
DOI
ScienceOn
|
12 |
Duffield-Lillico AJ, Dalkin BL, Reid ME, et al (2003). Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the nutritional prevention of cancer trial. BJU Int, 91, 608-12.
DOI
ScienceOn
|
13 |
Grundmark B, Zethelius B, Garmo H, et al (2011). Serum levels of selenium and smoking habits at age 50 influence long term prostate cancer risk; a 34 year ULSAM follow-up. BMC Cancer, 11, 431.
DOI
|
14 |
Hsing AW, Chokkalingam AP(2006). Prostate cancer epidemiology. Front Biosci, 11, 1388-413.
DOI
ScienceOn
|
15 |
Hurst R, Hooper L, Norat T, et al (2012). Selenium and prostate cancer: systematic review and meta-analysis. Am J Clin Nutr, 96, 111-22.
DOI
ScienceOn
|
16 |
Lippman SM, Goodman PJ, Klein EA, et al (2005). Designing the selenium and vitamin E cancer prevention trial (SELECT). J Natl Cancer Inst, 97, 94-102.
DOI
ScienceOn
|
17 |
Lippman SM, Klein EA, Goodman PJ, et al (2009). Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E cancer prevention trial (SELECT). JAMA, 301, 39-51.
DOI
ScienceOn
|
18 |
Marshall JR, Tangen CM, Sakr WA, et al (2011). Phase III trial of selenium to prevent [rostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prev Res (Phila), 4, 1761-9.
DOI
ScienceOn
|
19 |
Ozten N, Horton L, Lasano S, et al (2010). Selenomethionine and-tocopherol do not inhibit prostate carcinogenesis in the testosterone plus estradiol-treated NBL rat model. Cancer Prev Res (Phila), 3, 371-80.
DOI
ScienceOn
|
20 |
Rayman MP(2000). The importance of selenium to human health. Lancet, 356, 233-41.
DOI
ScienceOn
|